A rare inherited EGFR mutation raises lung cancer odds 25-fold overall and more than 60-fold in never-smokers, revealing why ...
Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer ...
The inherited mutation substantially increases the chance of developing lung cancer, including in people who don't smoke.
Lung cancer remains the deadliest malignancy on the planet, and a sweeping new analysis of twenty years of scientific ...
Lung cancer incidence decreased 3.5%/year in males and 1.9%/year in females during 2018–2022, alongside a two-thirds increase ...
Lung cancer screening eligibility increased markedly from 2018–2023 under USPSTF criteria, reflecting aging and substantial ...
C EGFR T790M gene variant face roughly 25 times the lung cancer risk of noncarriers, according to the largest-yet study of ...
The award will support the development of a noninvasive approach to determine whether indeterminate pulmonary nodules are ...
In Australia, lung cancer is the fourth most commonly diagnosed cancer and the leading cause of cancer mortality. ... Read More The post New research using the human breath could revolutionise lung ...
Cullinan Therapeutics announced that it has initiated submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration for zipalertinib in combination with plat ...
AI models accurately extracted smoking history to support lung cancer screening decisions. Read more about the findings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results